Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Pharmacor Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (608)
Cancellation by sponsor (84)
Prescription medicine registration (36)
Cancellation or suspension (19)

Date

2024 (48)
2023 (54)
2022 (131)
2021 (83)
2020 (79)
2019 (56)
2018 (91)
2017 (42)
2016 (24)
2015 (14)
2014 (56)
2013 (23)
2012 (11)
2011 (7)
2010 (19)
2009 (6)
2007 (2)
1991 (1)

Results for "[search-keyword]"

Search

Sponsor content

747 result(s) found, displaying 251 to 260

FURATEC dimethyl fumarate 240 mg delayed release capsule blister pack (309596)

14 July 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FURATEC dimethyl fumarate 240 mg delayed release capsule blister pack.
FURATEC dimethyl fumarate 120 mg delayed release capsule blister pack (309593)

14 July 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FURATEC dimethyl fumarate 120 mg delayed release capsule blister pack.
PHARMACOR DIMETHYL FUMARATE dimethyl fumarate 120 mg delayed release capsule blister pack (309592)

14 July 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHARMACOR DIMETHYL FUMARATE dimethyl fumarate 120 mg delayed release capsule blister pack.
AKM DIMETHYL FUMARATE dimethyl fumarate 120 mg delayed release capsule blister pack (309594)

14 July 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AKM DIMETHYL FUMARATE dimethyl fumarate 120 mg delayed release capsule blister pack.
PHARMACOR DIMETHYL FUMARATE dimethyl fumarate 240 mg delayed release capsule blister pack (309591)

14 July 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PHARMACOR DIMETHYL FUMARATE dimethyl fumarate 240 mg delayed release capsule blister pack.
PHARMACOR SITAGLIPTIN (Pharmacor Pty Ltd)

4 July 2022

Prescription medicine registration

Active ingredients: sitagliptin hydrochloride monohydrate.
TRUST RESTAMINE doxylamine succinate 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2022

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TRUST FOR KIDS IBUPROFEN SUSPENSION ibuprofen 20mg/mL oral liquid bottle Cancelled under Section 30(1)(c) of the Act

30 June 2022

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TRUST TERBINAFINE CREAM terbinafine hydrochloride 1% cream tube Cancelled under Section 30(1)(c) of the Act

30 June 2022

Cancellation by sponsor

Requested by Pharmacor Pty Ltd
TRUST FOR KIDS CETIRIZINE LIQUID cetirizine hydrochloride 5mg/5mL oral solution bottle Cancelled under Section 30(1)(c) of the Act

30 June 2022

Cancellation by sponsor

Requested by Pharmacor Pty Ltd

Pages

First page
Previous page
…
Page 22
Page 23
Page 24
Page 25
Current page 26
Page 27
Page 28
Page 29
Page 30
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.